244 related articles for article (PubMed ID: 25174659)
21. Changing the face of hepatitis C management - the design and development of sofosbuvir.
Noell BC; Besur SV; deLemos AS
Drug Des Devel Ther; 2015; 9():2367-74. PubMed ID: 25987834
[TBL] [Abstract][Full Text] [Related]
22. New antiviral therapies in the management of HCV infection.
Farnik H; Zeuzem S
Antivir Ther; 2012; 17(5):771-83. PubMed ID: 22626842
[TBL] [Abstract][Full Text] [Related]
23. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
Vagu C; Sultana C; Ruţă S
Roum Arch Microbiol Immunol; 2013; 72(1):5-24. PubMed ID: 23947011
[TBL] [Abstract][Full Text] [Related]
24. New developments in HCV therapy.
Kronenberger B; Zeuzem S
J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414
[TBL] [Abstract][Full Text] [Related]
25. A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir.
Chen EY; Sclair SN; Czul F; Apica B; Dubin P; Martin P; Lee WM
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1014-20.e1-2. PubMed ID: 23602817
[TBL] [Abstract][Full Text] [Related]
26. Telaprevir: hope on the horizon, getting closer.
Weisberg IS; Jacobson IM
Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
[TBL] [Abstract][Full Text] [Related]
27. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
Chevaliez S
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694
[TBL] [Abstract][Full Text] [Related]
28. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
Welsch C; Jesudian A; Zeuzem S; Jacobson I
Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
[TBL] [Abstract][Full Text] [Related]
29. Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection.
Trembling PM; Tanwar S; Dusheiko GM
Expert Rev Anti Infect Ther; 2012 Mar; 10(3):269-79. PubMed ID: 22397560
[TBL] [Abstract][Full Text] [Related]
30. Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors.
Welzel TM; Dultz G; Zeuzem S
J Hepatol; 2014 Nov; 61(1 Suppl):S98-S107. PubMed ID: 25443350
[TBL] [Abstract][Full Text] [Related]
31. Oral antiviral therapies for chronic hepatitis C infection.
Pol S; Corouge M; Sogni P
Ther Adv Infect Dis; 2013 Jun; 1(3):107-16. PubMed ID: 25165547
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chronic hepatitis C: current and future.
Pawlotsky JM
Curr Top Microbiol Immunol; 2013; 369():321-42. PubMed ID: 23463207
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis C treatment in special patient groups].
Berenguer M; Jorquera F; Ángel Serra M; Sola R; Castellano G
Gastroenterol Hepatol; 2014 Jul; 37 Suppl 1():23-36. PubMed ID: 25907435
[TBL] [Abstract][Full Text] [Related]
34. Antiviral therapies for chronic hepatitis C virus infection with cirrhosis.
Nakamoto S; Kanda T; Shirasawa H; Yokosuka O
World J Hepatol; 2015 May; 7(8):1133-41. PubMed ID: 26052402
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies.
Shahid I; ALMalki WH; Hafeez MH; Hassan S
Crit Rev Microbiol; 2016 Aug; 42(4):535-47. PubMed ID: 25373616
[TBL] [Abstract][Full Text] [Related]
36. Direct anti-HCV agents.
Zhang X
Acta Pharm Sin B; 2016 Jan; 6(1):26-31. PubMed ID: 26904396
[TBL] [Abstract][Full Text] [Related]
37. Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.
De Clercq E
Rev Med Virol; 2015 Jul; 25(4):254-67. PubMed ID: 26043288
[TBL] [Abstract][Full Text] [Related]
38. New hepatitis C therapies in clinical development.
Vermehren J; Sarrazin C
Eur J Med Res; 2011 Jul; 16(7):303-14. PubMed ID: 21813371
[TBL] [Abstract][Full Text] [Related]
39. New treatments for chronic hepatitis C.
Jang JY; Chung RT
Korean J Hepatol; 2010 Sep; 16(3):263-77. PubMed ID: 20924208
[TBL] [Abstract][Full Text] [Related]
40. Protease inhibitor therapy for hepatitis C virus-infection.
de Leuw P; Stephan C
Expert Opin Pharmacother; 2018 Apr; 19(6):577-587. PubMed ID: 29595065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
